In clinical practice BC is usually classified into three groups: hormonal estrogen (ER+) and progesterone receptor-positive (PR+), human epidermal growth factor receptor positive (HER2+) and triple negative (TNBC), that lacks expression of all these three receptors and is considered the most fatal form of BC. The gene discussed is ERBB2; the disease is breast cancer.